Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1970 Oct;40(2):294–309. doi: 10.1111/j.1476-5381.1970.tb09922.x

Effect of anti-proteases and hexadimethrine bromide on the release of a bradykinin-like substance during heating (46° C) of rat paws

J Garcia Leme, L Hamamura, M Rocha E Silva
PMCID: PMC1702900  PMID: 5312823

Abstract

1. The conditions in which the release of an active, bradykinin-like agent occurred when rat paws were heated to 46° C were studied by means of the double coaxial perfusion of the subcutaneous spaces.

2. The active material thus released stimulated the isolated rat uterus, produced a relaxing effect on the isolated rat duodenum, was destroyed by incubation with chymotrypsin and was potentiated by bradykinin-potentiating factor. LSD-25, in doses sufficient completely to block 5-hydroxytryptamine, did not affect the responses of the isolated uterus to the active material.

3. The effects on this release of anti-proteases and hexadimethrine bromide, atropine and diphenhydramine were studied.

4. Soy-bean trypsin inhibitor and hexadimethrine bromide added to the perfusion fluid produced a potent and reversible inhibition of the release of the active material; aprotinin and Kunitz inhibitor caused a temporary block.

5. When administered intravenously, much larger doses of the substances were necessary to produce a similar block.

6. Pretreatment of the animals with atropine plus diphenhydramine did not affect the release of the active kinin(s).

7. Ligature of one iliac artery was followed by disappearance of the active material in the perfusate from the corresponding paw.

8. These facts suggest that heating elicits a process leading to plasma extravasation and that the subcutaneous tissue is the chief site of release of the active material.

Full text

PDF
294

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARMSTRONG D. A., STEWART J. W. Anti-heparin agents as inhibitors of plasma kinin formation. Nature. 1962 May 19;194:689–689. doi: 10.1038/194689a0. [DOI] [PubMed] [Google Scholar]
  2. EDERY H., LEWIS G. P. KININ-FORMING ACTIVITY AND HISTAMINE IN LYMPH AFTER TISSUE INJURY. J Physiol. 1963 Dec;169:568–583. doi: 10.1113/jphysiol.1963.sp007280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. FERREIRA S. H. A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA. Br J Pharmacol Chemother. 1965 Feb;24:163–169. doi: 10.1111/j.1476-5381.1965.tb02091.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Greenbaum L. M., Freer R., Chang J., Semente G., Yamafuji K. PMN-kinin and kinin metabolizing enzymes in normal and malignant leucocytes. Br J Pharmacol. 1969 Jul;36(3):623–634. doi: 10.1111/j.1476-5381.1969.tb08017.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HLADOVEC J., MANSFELD V., HORAKOVA Z. Inhibitory action of trypsin and trypsin-inhibitors on experimental inflammation in rats. Experientia. 1958 Apr 15;14(4):146–147. doi: 10.1007/BF02157129. [DOI] [PubMed] [Google Scholar]
  6. KELLETT D. N. ON THE ANTI-INFLAMMATORY ACTIVITY OF PROTAMINE SULPHATE AND OF HEXADIMETHRINE BROMIDE, INHIBITORS OF PLASMA KININ FORMATION. Br J Pharmacol Chemother. 1965 Jun;24:705–713. doi: 10.1111/j.1476-5381.1965.tb01626.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaller H., Hoffmeister F., Kroneberg G. Die Wirkung von Trasylol auf verschiedene Odemformen der Rattenpfote. Arch Int Pharmacodyn Ther. 1966 Jun;161(2):398–409. [PubMed] [Google Scholar]
  8. LEWIS G. P. PLASMA KININS AND OTHER VASOACTIVE COMPOUNDS IN ACUTE INFLAMMATION. Ann N Y Acad Sci. 1964 Aug 27;116:847–854. doi: 10.1111/j.1749-6632.1964.tb52550.x. [DOI] [PubMed] [Google Scholar]
  9. MONGAR J. L., SCHILD H. O. Effect of temperature on the anaphylactic reaction. J Physiol. 1957 Feb 15;135(2):320–338. doi: 10.1113/jphysiol.1957.sp005713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. ROCHA E SILVA M., ANTONIO A. Release of bradykinin and the mechanism of production of a "thermic edema (45 degrees C)" in the rat's paw. Med Exp Int J Exp Med. 1960;3:371–382. [PubMed] [Google Scholar]
  11. ROCHA E SILVA M., ROSENTHAL S. R. Release of pharmacologically active substances from the rat skin in vivo following thermal injury. J Pharmacol Exp Ther. 1961 Apr;132:110–116. [PubMed] [Google Scholar]
  12. Starr M. S., West G. B. Bradykinin and oedema formation in heated paws of rats. Br J Pharmacol Chemother. 1967 Sep;31(1):178–187. doi: 10.1111/j.1476-5381.1967.tb01988.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. WILHELM D. L., MASON B. Vascular permeability changes in inflammation: the role of endogenous permeability factors in mild thermal injury. Br J Exp Pathol. 1960 Oct;41:487–506. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES